Miguel Coego Rios
Director Financiero/CFO en CENTOGENE N.V. .
Cargos activos de Miguel Coego Rios
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| CENTOGENE N.V. | Director Financiero/CFO | 31/03/2022 | - |
| Consejero General | 08/02/2022 | - |
Historial de carrera de Miguel Coego Rios
Antiguos cargos conocidos de Miguel Coego Rios.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| SHIRE | Corporate Officer/Principal | 01/01/2011 | 01/01/2019 |
Mundipharma International Ltd.
 Mundipharma International Ltd. Pharmaceuticals: MajorHealth Technology Mundipharma International Ltd. develops and produces pharmaceutical products. It offers analgesics, oncology, respiratory, gastrointestinal, and cardiovascular drugs. The company was founded in 1952 and is headquartered in Cambridge, the United Kingdom. | Corporate Officer/Principal | - | - |
| ORPHAZYME A/S | Corporate Officer/Principal | - | - |
Estadísticas
Internacional
| Alemania | 2 |
| Dinamarca | 2 |
| Reino Unido | 2 |
Operativa
| Corporate Officer/Principal | 3 |
| Director of Finance/CFO | 1 |
| General Counsel | 1 |
Sectorial
| Health Technology | 4 |
| Commercial Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| CENTOGENE N.V. | Commercial Services |
| ORPHAZYME A/S | Health Technology |
| Empresas privadas | 2 |
|---|---|
Mundipharma International Ltd.
Mundipharma International Ltd. Pharmaceuticals: MajorHealth Technology Mundipharma International Ltd. develops and produces pharmaceutical products. It offers analgesics, oncology, respiratory, gastrointestinal, and cardiovascular drugs. The company was founded in 1952 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
Shire Plc
 Shire Plc Pharmaceuticals: MajorHealth Technology Shire Plc is a biopharmaceutical company, which engages in the research, development, licensing, manufacturing, marketing, distribution, and sale of medicines. Its products include adderall, advate, adynovate, agrylin, antithrombin 3, aralast, bebulin, buccolam, feiba, firazyr, and foznol. The company was founded in 1986 and is headquartered in Dublin, Ireland. | Health Technology |
- Bolsa de valores
- Insiders
- Miguel Coego Rios
- Experiencia
